forecast
Incentives Could Stall Fundamental Research
Alex worries that if innovation incentives weaken, companies will stop investing in fundamental, decade-long research, instead marketing old drugs, extending patents, and investing in hard-to-copy products like radiotherapeutics and CAR Ts.
forecastpending
Speaker
AlexEvidence Quote
“And then you're just going to sit on existing treatments and try to milk them as much as possible and use tricks and techniques to extend the patent life”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...